The safety and feasibility of inhaled amikacin for treatment of refractory chronic lower respiratory tract infections
Not Applicable
- Conditions
- chronic lower respiratory tract infections
- Registration Number
- JPRN-UMIN000017874
- Lead Sponsor
- Center for Infectious Diseases and Infection Control, Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Drug allergy of amikacin
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method